1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Taiwan >
  5. Polaris Group Acquires Genovior Biotech

M&A Deal Summary

Polaris Group Acquires Genovior Biotech

On December 21, 2023, Polaris Group acquired life science company Genovior Biotech

Acquisition Highlights
  • This is Polaris Group’s 1st transaction in the Life Science sector.
  • This is Polaris Group’s 1st transaction in Taiwan.

M&A Deal Summary
Date 2023-12-21
Target Genovior Biotech
Sector Life Science
Buyer(s) Polaris Group
Deal Type Add-on Acquisition

Target

Genovior Biotech

Miaoli, Taiwan
Genovior Biotech is a dedicated CDMO focus on process development, scale up, formulation development, and productivity optimization under PIC/S GMP. Genovior Biotech is based in Miaoli, Taiwan.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Polaris Group

Tampa, Florida, United States
Category Company
Sector Life Science
Revenue 107M USD (2024)
DESCRIPTION

Polaris Group is a biopharmaceutical company dedicated to pioneering advanced therapies, primarily focusing on metabolic related diseases. Polaris Group is based in Tampa, Florida.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Taiwan M&A 1 of 1
Year: 2023 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal